L
Lin Wang
Researcher at Zhengzhou University
Publications - 74
Citations - 2439
Lin Wang is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Glioma & Carcinogenesis. The author has an hindex of 26, co-authored 66 publications receiving 1871 citations. Previous affiliations of Lin Wang include Thomas Jefferson University & Nanjing Medical University.
Papers
More filters
Journal ArticleDOI
Genome-wide association study identifies a new susceptibility locus for cleft lip with or without a cleft palate
Yimin Sun,Yongqing Huang,Aihua Yin,Yongchu Pan,Yirui Wang,Cheng Wang,Yong Du,Meilin Wang,Feifei Lan,Zhibin Hu,Guoqing Wang,Min Jiang,Junqing Ma,Xiaozhuang Zhang,Hongxia Ma,Jian Ma,Weibing Zhang,Qun Huang,Zhongwei Zhou,Lan Ma,Yadi Li,Hongbing Jiang,Lan Xie,Yuyang Jiang,Bing Shi,Jing Cheng,Hongbing Shen,Lin Wang,Yinxue Yang +28 more
TL;DR: A case-control-based GWAS followed by two rounds of replication is conducted to elucidate the genetic architecture of NSCL/P in China and provides additional evidence that the rs2235371-related haplotype at 1q32.2 could play a more important role than the previously identified causal variant rs642961 in Chinese populations.
Journal ArticleDOI
MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.
Xu Qian,Jing Yu,Yu Yin,Yu Yin,Jun He,Lin Wang,Qi Li,Lou Qian Zhang,Chong yong Li,Zhu Mei Shi,Qing Xu,Wei Li,Li Hui Lai,Ling-Zhi Liu,Bing-Hua Jiang,Bing-Hua Jiang +15 more
TL;DR: Levels in human blood and tumor tissues are associated with CRC cancer occurrence, metastasis and drug resistance, and miR-143 levels may be used as a new diagnostic marker and therapeutic target for CRC in the future.
Journal ArticleDOI
Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy
TL;DR: MIR152 is reported as a new autophagy-regulating miRNA that plays a role in cisplatin-resistance and it is found that EGR1 (early growth response 1) regulated the MIR152 gene at the transcriptional level.
Journal ArticleDOI
MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma
Lin Wang,Zhu Mei Shi,Cheng fei Jiang,Xue Liu,Qiu Dan Chen,Xu Qian,Dong mei Li,Xin Ge,Xie feng Wang,Ling-Zhi Liu,Yong ping You,Ning Liu,Bing-Hua Jiang +12 more
TL;DR: It is demonstrated that miR-143 plays a significant role in inactivating the RAS signaling pathway through the inhibition of N-RAS, which may provide a novel therapeutic strategy for treatment of glioma and other RAS-driven cancers.
Journal ArticleDOI
MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras
Zhumei Shi,Qiudan Chen,Chongyong Li,Lin Wang,Xu Qian,Cheng-Fei Jiang,Xue Liu,Xiefeng Wang,Hai Li,Chunsheng Kang,Tao Jiang,Ling-Zhi Liu,Yongping You,Ning Liu,Bing-Hua Jiang,Bing-Hua Jiang +15 more
TL;DR: MiR-124 levels in tumor tissues are associated with glioma occurrence, angiogenesis, and chemoresistance and that miR- 124 may be used as a new diagnostic marker and therapeutic target forglioma in the future.